Comparison of Ciprofloxacin Ophthalmic Solution 0.3% to Fortified Tobramycin-Cefazolin in Treating Bacterial Corneal Ulcers

Authors :: Hyndiuk, Robert A.
Eiferman, Richard A.
Caldwell, Delmar R.
Rosenwasser, George O.
Santos, Carmen I.
Katz, Harold R.
Badrinath, Sengamedu S.
Reddy, Madhukar K.
Adenis, Jean-Paul
Klauss, Volker
Adenis, J.P.
Badrinath, S.S.
Caldwell, D.R.
Cohen, E.
Marechal-Courtois, C.
Murta, J.
Darrell, R.W.
Denis, P.
Eiferman, R.A.
Heidemann, D.H.
Hyndiuk, R.A.
Insler, M.S.
John, T.
Katz, H.R.
Klauss, V.
Lass, J.H.
Limberg, M.B.
McCulley, J.P.
Reddy, M.K.
Rosenwasser, G.O.D.
Rowsey, J.J.
Santos, C.
Sher, N.
Ullman, S.
Verin, P.
Wilhelmus, K.R.
Wills, R.
Wolf, T.C.
Source :: Ophthalmology; January 1996, Vol. 103 Issue: 11 p1854-1863, 10p
Publication Year :: 1996
Abstract: Purpose:The purpose of the study is to compare the clinical efficacy and safety of ciprofloxacin ophthalmic solution 0.3% (Ciloxan) with a standard therapy regimen (fortified tobramycin, 1.3%-cefazolin, 5.0%) for treating bacterial corneal ulcers.

Full Text Access

Tools